z-logo
open-access-imgOpen Access
Should We Utilize Maintenance Therapy Post-Hematopoietic Cell Transplantation in Patients With FLT3/ITD-positive AML?
Author(s) -
Amy E. DeZern
Publication year - 2019
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v16.4.9638
Subject(s) - hematopoietic cell , maintenance therapy , hematopoietic stem cell transplantation , haematopoiesis , medicine , oncology , transplantation , stem cell , biology , chemotherapy , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom